Podcast

October 12, 2019

Podcast: This Week in Managed Care—Medicare Executive Order and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care^® recaps the top managed care news of the week.

This week, the top managed care news included an effort by the Trump administration to bolster Medicare Advantage; an abortion case from Louisiana reached the Supreme Court; the study of adapting to changing oxygen levels wins the Nobel Prize.

Listen above or through one of these podcast services:

Trump Executive Order Bolsters Medicare, MA to Compete Against "Medicare for All" Proposals

What We're Reading: Abortion Access Appeal; Trump to Suspend Visas for Uninsured Immigrants; Vape Ban in Oregon

Nobel Prize Honors 3 Who Showed How Cells Adapt to Oxygen Levels

California Becomes First State to Make HIV Prevention Medication Accessible Without a Prescription

Psych Congress 2019

Read more about the stories in this podcast:

Related Videos

Benjamin Chen, MD, PhD

Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)

Benjamin Chen, MD, PhD

JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)

Lynae Darbes, PhD

Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD

Galen Shearn-Nance, BS

Dr Johnie Rose

Bridgette Picou, LVN, ACLPN, The Well Project

Adam Colburn, JD, associate vice president for congressional affairs, AMCP

Related Content

glp-1 Wegovy, semaglutide | Image credit: Patrick Bay Damsted - stock.adobe.com

April 25th 2025

Can Medicare Sustain Widespread Access to GLP-1 Therapies?

Skylar Jeremias

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

Richard Hughes IV, JD, MPH

April 21st 2025

What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV

Julia Bonavitacola Richard Hughes IV, JD, MPH

Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

The White House | Image credit: Maksym Yemelyanov - stock.adobe.com

April 16th 2025

Trump Signs Executive Order to Lower Drug Prices

The executive order targets lower drug prices through Medicare reforms, anticompetitive crackdowns, and transparency mandates.

Seniors receiving health care | Image credit: Adobe.com

April 11th 2025

Sutter Health, SCAN Announce Partnership to Launch New MA Products, Joint Venture Health Plan

The California-based entities plan to offer new Medicare Advantage (MA) products in select counties by this fall.

Related Content

glp-1 Wegovy, semaglutide | Image credit: Patrick Bay Damsted - stock.adobe.com

April 25th 2025

Can Medicare Sustain Widespread Access to GLP-1 Therapies?

Skylar Jeremias

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

Richard Hughes IV, JD, MPH

April 21st 2025

What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV

Julia Bonavitacola Richard Hughes IV, JD, MPH

Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

The White House | Image credit: Maksym Yemelyanov - stock.adobe.com

April 16th 2025

Trump Signs Executive Order to Lower Drug Prices

The executive order targets lower drug prices through Medicare reforms, anticompetitive crackdowns, and transparency mandates.

Seniors receiving health care | Image credit: Adobe.com

April 11th 2025

Sutter Health, SCAN Announce Partnership to Launch New MA Products, Joint Venture Health Plan

The California-based entities plan to offer new Medicare Advantage (MA) products in select counties by this fall.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions